@alicenomalice on the role of IV antiplatelets for acute large vessel occlusion. #SNIS2025 @SNISInfo @esmintsociety @cvsection @fcalbuquerque51 @dr_mchen @DanniDiestro @MattAmansMD @ducruetaf @MattFusco_MD @DrAltschul @cruzcerebri @niko_mou @aliyasiddiqui04

#STROKE: Review by @amrsarrajMD et al. of the six recent RCTs of thrombectomy in large core strokes with the exploration of what expanding eligibility could mean for stroke care systems and society. #ESOC2025 #AHAJournals https://t.co/37TeNCb7MD

Endovascular management of acute stroke https://t.co/YKqmqA6pk6 @TheLancet @AbdalkaderMD @FishingNeurons @NagelSimon @ZhongrongMiao @PoojaKhatriMD

SVIN familia 🧠🙌🏽

Great to meet many @svinsociety friends & colleagues at #SVINAM23. Bravo @almuftifawaz @AlexandraCzap et al. for an outstanding program, including trial results and upcoming protocols: SEGA RCT @RocChenMD, ALLY, DAISE, FIRST, CHESS, SOFAST, CLASS, PLATO https://t.co/KtPaUEwc8p

Unplanned events are some of the best encounters at an annual meeting. Happy to have run into the @WFITN_Society leadership, Dr. Seon Kyu Lee, Dr. Michiro Tanaka, Dr. Laurent Spelle, to think about collaborations between @svinsociety and WFITN.

LATE BREAKING @ @svinsociety #SVIN23 by the luminary trailblazer @TudorGJovin First Presentation of the LASTE trial (in North America). Prospective multicenter Blinded randomized Trial 30 CSC >320pts 1⁰ Outcome for Disability OR1.63 favoring EVT! NNT :4.2 (95%CI, 2.8 to 7.8)

Does the core matter anymore ???!!

Massive congratulations to Dr @NguyenThanhMD, so inspirational because of her passion for clinical neuroscience and endovascular treatments, promoting accessibility and widespread adoption, fantastic researcher and scientist, and gracious always to elevate all those around her

WIN behind the scenes!! Be a part of SVINAM and indulge in the WIN and DEI Reception for a remarkable evening celebrating diversity🌍 🗓️ Fri, Nov 17th ⏰ 5:30 PM 📍 Glimmer Ballroom 🌐 Spread the word, and let's empower each other in this incredible field! #SVIN2023 #WINN

The SEGA RCT trial presented by @RocChenMD for the first time @svinsociety #SVIN23 Sedation vs General Anestgesia for EVT for AI: RCT of 260 patients! GA assoc. w better ⬆️ outcomes(OR 1.2) & Reperfusion(OR 1.02) Ground breaking research at #SVIN23: https://t.co/w4EGAZT881

Learned something at the museum

Happening now📌 IV Antiplatelet Therapy in ICAD or Tandem LVO @NguyenThanhMD 🧠High rates of stent reocclusion 🛡️Urgent need to determine optimal antiplatelet therapy for reocclusion prevention ⚠️Transitioning to oral therapy correctly is crucial – NO GAPs #CLASStrial #SVIN2023

Thanks @almuftifawaz for the invitation to #SVIN2023 #SVINinsights #MiamiBeach

Thanks for the shout out @NguyenThanhMD #SVIN23 Antiplatelets in Neurointervention https://t.co/QViQzSqOh5

Great to be @Svin2023 Miami, the next generation of neurointerventional devices, BCI and AI and advances in neurointervention

Great to share a panel, learn from Professor Bernard Yan re Bridging controversies in Stroke, Dr. Alice Ma @alicenomalice on Antithrombotics post stent insertion at the 2022 Australasian Stroke Academy, moderated by Professor Mark Parsons @WomenInNeuroIR

@NguyenThanhMD @WomenInNeuroIR Great to be on the same Neuro Interventional panel as my mentor @NguyenThanhMD

👉🏽Excited about our first “Brief Practice Update” Statement from @svinsociety Guidelines & Practice Standards Committee on Prethrombectomy Thrombolysis in #LVO #Stroke 🧠⚡️ https://t.co/Hm52HS0deM stay tuned for more practice-centric expert analysis & recs @oozaidat @AmerMalikMD

Global impact of COVID19 on CVT & mortality. MMQ @PiersKlein @ShadiYaghi2 @Diana_A_Sousa @VancouverStroke @JimSiegler @ossama_mansour @DStrambo @SomaBanerjee73 @MicheleRomoli @sedovapetra @NagelSimon @arsovska_anita @AbdalkaderMD @RaulNogueiraMD https://t.co/0Y54bOqVDM